Cargando…

Divalent cations in human liver pyruvate kinase exemplify the combined effects of complex-equilibrium and allosteric regulation

There is growing recognition that the functional outcome of binding of an allosteric regulator to a protein/enzyme is influenced by the presence of other ligands. Here, this complexity is exemplified in the allosteric regulation of human liver pyruvate kinase (hLPYK) that is influenced by the presen...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin, Tyler A., Fenton, Aron W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310847/
https://www.ncbi.nlm.nih.gov/pubmed/37386072
http://dx.doi.org/10.1038/s41598-023-36943-2
_version_ 1785066620556673024
author Martin, Tyler A.
Fenton, Aron W.
author_facet Martin, Tyler A.
Fenton, Aron W.
author_sort Martin, Tyler A.
collection PubMed
description There is growing recognition that the functional outcome of binding of an allosteric regulator to a protein/enzyme is influenced by the presence of other ligands. Here, this complexity is exemplified in the allosteric regulation of human liver pyruvate kinase (hLPYK) that is influenced by the presence of a range of divalent cation types and concentrations. For this system, fructose-1,6-bisphosphate (activator) and alanine (inhibitor) both influence the protein’s affinity for the substrate, phosphoenolpyruvate (PEP). Mg(2+), Mn(2+), Ni(2+), and Co(2+) were the primary divalent cations evaluated, although Zn(2+), Cd(2+), V(2+), Pb(2+), Fe(2+), and Cu(2+)also supported activity. Allosteric coupling between Fru-1,6-BP and PEP and between Ala and PEP varied depending on divalent cation type and concentration. Due to complicating interactions among small molecules, we did not attempt the fitting of response trends and instead we discuss a range of potential mechanisms that may explain those observed trends. Specifically, observed “substrate inhibition” may result from substrate A in one active site acting as an allosteric regulator for the affinity for substrate B in a second active site of a multimer. We also discuss apparent changes in allosteric coupling that can result from a sub-saturating concentration of a third allosteric ligand.
format Online
Article
Text
id pubmed-10310847
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-103108472023-07-01 Divalent cations in human liver pyruvate kinase exemplify the combined effects of complex-equilibrium and allosteric regulation Martin, Tyler A. Fenton, Aron W. Sci Rep Article There is growing recognition that the functional outcome of binding of an allosteric regulator to a protein/enzyme is influenced by the presence of other ligands. Here, this complexity is exemplified in the allosteric regulation of human liver pyruvate kinase (hLPYK) that is influenced by the presence of a range of divalent cation types and concentrations. For this system, fructose-1,6-bisphosphate (activator) and alanine (inhibitor) both influence the protein’s affinity for the substrate, phosphoenolpyruvate (PEP). Mg(2+), Mn(2+), Ni(2+), and Co(2+) were the primary divalent cations evaluated, although Zn(2+), Cd(2+), V(2+), Pb(2+), Fe(2+), and Cu(2+)also supported activity. Allosteric coupling between Fru-1,6-BP and PEP and between Ala and PEP varied depending on divalent cation type and concentration. Due to complicating interactions among small molecules, we did not attempt the fitting of response trends and instead we discuss a range of potential mechanisms that may explain those observed trends. Specifically, observed “substrate inhibition” may result from substrate A in one active site acting as an allosteric regulator for the affinity for substrate B in a second active site of a multimer. We also discuss apparent changes in allosteric coupling that can result from a sub-saturating concentration of a third allosteric ligand. Nature Publishing Group UK 2023-06-29 /pmc/articles/PMC10310847/ /pubmed/37386072 http://dx.doi.org/10.1038/s41598-023-36943-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Martin, Tyler A.
Fenton, Aron W.
Divalent cations in human liver pyruvate kinase exemplify the combined effects of complex-equilibrium and allosteric regulation
title Divalent cations in human liver pyruvate kinase exemplify the combined effects of complex-equilibrium and allosteric regulation
title_full Divalent cations in human liver pyruvate kinase exemplify the combined effects of complex-equilibrium and allosteric regulation
title_fullStr Divalent cations in human liver pyruvate kinase exemplify the combined effects of complex-equilibrium and allosteric regulation
title_full_unstemmed Divalent cations in human liver pyruvate kinase exemplify the combined effects of complex-equilibrium and allosteric regulation
title_short Divalent cations in human liver pyruvate kinase exemplify the combined effects of complex-equilibrium and allosteric regulation
title_sort divalent cations in human liver pyruvate kinase exemplify the combined effects of complex-equilibrium and allosteric regulation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310847/
https://www.ncbi.nlm.nih.gov/pubmed/37386072
http://dx.doi.org/10.1038/s41598-023-36943-2
work_keys_str_mv AT martintylera divalentcationsinhumanliverpyruvatekinaseexemplifythecombinedeffectsofcomplexequilibriumandallostericregulation
AT fentonaronw divalentcationsinhumanliverpyruvatekinaseexemplifythecombinedeffectsofcomplexequilibriumandallostericregulation